All eyes are on the next wave of CAR and TCR innovation. Success is no longer defined by clinical wins alone, but by smarter biological design, delivery strategies and manufacturing breakthroughs to lower COGs, expand patient access and secure commercial viability.

With this, the 11^th CAR-TCR Summit is making its hotly anticipated return to Boston, September 15-17.

View the agenda here.

Crafted in collaboration with industry veterans and spanning four tracks across the entire development life cycle, the program offers a clear, strategic view of the next era of cell therapy. Expect first hand insight into cutting-edge in vivo and next generation CAR and TCR innovations, hear unpublished clinical data across emerging indications, and learn from real world automated manufacturing case studies shaping commercial readiness.

Beyond the science, you’ll gain direct access to investors to align on where capital and strategic partnerships are moving next, complemented by high-value networking with C-suite executives and academic KOLs to safegaurd every stage of your cell therapy development pipeline.

If you’re committed to driving the innovation and commercial readiness needed to make CAR-T therapies safer, more effective, scalable, and accessible to the patients who need them most, then this is the meeting for you.

Download your copy of the agenda.